Preliminary Agenda

Day 1: 06 September 2024

1:00 PM

Scientific Session A: New Horizon in Autoimmunity

Translational medicine: lessons from autoinflammatory disorders

Prof. Panagiotis Skendros

Democritus University of Thrace, University Hospital of Alexandroupolis, Greece

2:00 PM

Scientific Session B: New developments in Genitourinary Tumors

SMART Diagnostics: From Single-Cell Diagnostics to MUSE Microscopy

Prof. Jianyu Rao

Department of pathology and laboratory medicine at University of California at Los Angeles, Los Angeles CA, USA

3:00 PM

Scientific Session C: New developments in Gastrointestinal (GI) Tumors

AI-derived precision diagnosis, focusing on pancreatic cancer

Prof. Gary Xiao

Molecular Pharmacology, School of Chemical Engineering, Dalian University of Technology, Dalian, China

4:00 PM

Scientific Session D: Autoimmune Diseases: New Findings & Early Detection

Spotting ILD in Autoimmune Disease: The Role of POCUS in Early Detection and Disease Monitoring

Dr. Nour Al Jalbout

Harvard Emergency Ultrasound Fellowship Program and Emergency Medicine, Harvard Medical School, USA

5:00 PM

Scientific Session E: New Horizon in Breast Tumors

Developing immune therapies for prevention in breast cancer

Dr Sasha Stanton

Providence Cancer Institute, Portland, OR, USA

6:00 PM

Scientific Session F: New Horizon in Immunotherapeutics

Clonal hematopoiesis and chronic disease

Prof. George Hajishengallis

University of Pennsylvania, Penn Dental Medicine
Department of Basic & Translational Sciences, Philadelphia, PA, USA

Day 2: 07 September 2024

2:00 PM

Scientific Session A: Modern updates in Immuno-Oncology

PD-L1+ aneuploid circulating tumor endothelial cells (CTECs) detected by SE-iFISH in patients with NSCLC or melanoma exhibit resistance to ICI immunotherapy

Prof. Peter Lin

Cytelligen, San Diego, CA, USA

3:00 PM

Scientific Session B: New Horizon in Immunotherapeutics

Multiple, consecutive quality checkpoints significantly improve the value of the bio-banked material for research

Jeffery Kimbrough

Head of Strategic Partnerships, Genomics Subject Matter Expert, Reference Medicine, USA

4:00 PM

Scientific Session C: Novel Developments in Infectious diseases

Cysteamine as a host-directed therapy for infectious diseases

Dr Delia Goletti

Rome, Italy

5:00 PM

Scientific Session D: Autoimmune Disease: Immunotherapy and Diagnostics

POCUS in Autoimmune Disease: Early Diagnosis and Tracking Response to Immunotherapy

Dr. Minna Kohler

Massachusetts General Hospital (MGH), Boston, USA

6:00 PM

Scientific Session E: New Horizon in Autoimmunity

Inflammatory pathways in the spondyloarthritis spectrum and treatment considerations

Charalampos Papagoras

Democritus University of Thrace, University Hospital of Alexandroupolis, Greece

7:00 PM

Scientific Session F: Tumors Immunobiology: New Findings & Solutions

Targeting axonal guidance dependencies in glioblastoma with ROBO1 CAR-T cells

Sheila K. Singh

McMaster Children’s Hospital, Hamilton, ON, Canada

Day 3: 08 September 2024

1:00 PM

Scientific Session B: New Horizon in Immunotherapeutics

M as in miconazole, mithocondria, melanoma

Prof. Antonio Facchiano

Rome, Italy

2:00 PM

Scientific Session A: Tumors Immunobiology: New Findings & Solutions

Engineering T cells to overcome immune suppression in the solid tumor microenvironment

Kristin Anderson

Beirne B. Carter Center for Immunology Research, University of Virginia Comprehensive Cancer Center, Charlottesville, VA, USA

3:00 PM

Scientific Session F: New Therapeutic Solutions in GI Cancers

Immunotherapy in GI Cancers: Recent Developments

Dr Andrew L. Coveler

Fred Hutchinson Cancer Center, University of Washington Division of Hematology and Oncology, Seattle, WA, USA

4:00 PM

Scientific Session D: Novel Developments in POC Diagnostics

Prof. Hamid Shokoohi

Harvard Medical School, Department of Emergency Medicine, Massachusetts General Hospital, Harvard, USA

5:00 PM

Scientific Session E: New Horizon in Autoimmunity

CAR-cell therapies in autoimmunity

Dr Konstantinos Tselios

Department of Medicine, McMaster University, Hamilton, ON, Canada

6:00 PM

Scientific Session F: New Horizon in Immunotherapeutics

Echoing the Immune Response: MSK Ultrasound in Checkpoint Inhibitor-Related Immunotherapy Adverse Events

Dr. Minna Kohler

Massachusetts General Hospital (MGH), Boston, USA

★ Agenda is being updated regularly